Turnbull J. Reappraisal of an ALS trial: unaccounted procedural risk. Lancet Neurol. 2020 Sep;19(9):717-718. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

Therapeutics

  1. Edaravone